Navigation Links
Treatment with Elekta's Leksell Gamma Knife Perfexion Introduced to Cancer Patients in Australia
Date:8/19/2010

SYDNEY and ATLANTA, Aug. 19 /PRNewswire/ -- On August 3, Macquarie University Hospital (MUH) performed Australia's first Gamma Knife® surgery with its new Leksell Gamma Knife® Perfexion™ system, making it the country's first and only center capable of providing dedicated intracranial radiosurgery. MUH and the Australian School of Advanced Medicine (ASAM) partnered with Genesis Care, Australia's leading provider of cancer management services, to procure the system, which is located in Genesis Care's radiation therapy department at MUH.

MUH's first radiosurgery patient, a 33-year-old man with multiple small brain tumors, underwent a 100-minute Gamma Knife surgery treatment and was able to return home the same day, according to John Fuller, M.D., Macquarie neurosurgeon and Gamma Knife program co-director.

"He was awake during the whole procedure and received only a local anesthetic," Dr. Fuller reports. "The gentleness of Gamma Knife surgery not only benefits patients, but also extends to their families, our treatment team and the healthcare system as a whole."

Gamma Knife radiosurgery is a patient friendlier alternative to traditional brain surgery for illnesses such as metastatic disease, which is cancer that has travelled to the brain from elsewhere in the body. With pinpoint accuracy, the system delivers up to thousands of low-intensity radiation beams to one or more targets in a single session. Perfexion, the latest generation Gamma Knife model, provides even greater speed and ease of use than previous models.

"The Perfexion improvements enable greater ability to treat multiple targets in a single session, and Gamma Knife retains its status as intracranial gold standard," says Professor Michael K
'/>"/>

SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs
2. Varian Medical Systems to Showcase Advanced Motion Management Technology for the Treatment of Lung Cancer at CHINA-HOSPEQ 2010
3. Chula Vistas Dr. Peter Rullan Adds Alma Lasers Pixel CO2 Laser System to Offer Fractional CO2 Laser Treatments to Patients
4. In First- and Second-Line Treatment of Clostridium Difficile Infection, Nearly 70 Percent of Surveyed Infectious Disease Specialists and Internists Will Use Fidaxomicin and Nearly Half Will Use CDA1/CDB1
5. FDA Approves Merz Pharmaceuticals Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
6. Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions
7. ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24
8. EMD Serono, Inc.: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS
9. RoboticOncology.com: Robotic Surgeon Dr. David Samadi, MD Introduces His SMART Surgery Technique for Prostate Cancer Treatment
10. Study Seeks Volunteers to Measure Safety of Treatment Boost for Patients with Oropharyngeal Cancer
11. Elusys Therapeutics and Lonza Extend Manufacturing Agreement for Anthim, a New Anthrax Treatment in Late-Stage Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , Aug. 3, 2015 Par Pharmaceutical ... conference call on Friday, August 7, 2015 at 9:00 ... the second quarter ended June 30, 2015.  Par is ... to the public in its filings with the Securities ... available on its website by following the instructions at ...
(Date:8/3/2015)... , Aug. 3, 2015 OmniSeq, LLC ... Institute to the OmniSeq SM Genomic Network.  ... Cancer Institute (RPCI) and announced it was making ... a physician-driven, collaborative approach to genomic diagnostics that ... Cancer Institute is a rapidly expanding, multidisciplinary cancer ...
(Date:8/3/2015)...  Sage Analytics ( www.sageanalytics.com ), the developers of ... systems, announced its sponsorship of the California Cannabis Industry ... number of tickets are available for groups or individuals ... while enjoying an open bar, buffet dinner and hors ... Bay at sunset. With the legislative session ...
Breaking Medicine Technology:OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 2OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 3Sage Analytics Sponsors California Cannabis Industry Association Bay Area Cruise FUNdraiser 2
... YORK, April 9, 2008 Intra-Cellular Therapies, ... ongoing development,programs for ITI-007, the Company,s first-in-class ... and ITI-722,a low-dose formulation of ITI-007, which ... respectively. These new data demonstrate,ITI-007 has preclinical ...
... ... - Preliminary Phase I/II results to be presented in June at 2008 ... ... ), a clinical-stage biopharmaceutical company,focused on oncology, announced today that it has advanced CR011-vcMMAE, ...
Cached Medicine Technology:Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722 2Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722 3CuraGen Advances CR011-vcMMAE into Phase II 2CuraGen Advances CR011-vcMMAE into Phase II 3CuraGen Advances CR011-vcMMAE into Phase II 4
(Date:8/3/2015)... ... August 03, 2015 , ... The Workgroup for Electronic Data Interchange ... to create efficiencies in healthcare information exchange, announced the release of its findings from ... Human Services (HHS) Secretary, WEDI shared survey results and recommendations , ...
(Date:8/3/2015)... Angeles, California (PRWEB) , ... August 03, 2015 ... ... on the Atlanta Journal Constitution, the new Lifetime reality series, “Atlanta Plastic” ... who performs and who receives plastic surgery, with its predominantly African-American cast of ...
(Date:8/3/2015)... ... August 03, 2015 , ... According to an opinion piece published July 28 by ... to one pound of weight loss may not be accurate. While this system may work ... pound of fat varies – based both on the individual and at what point that ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... They know ... Providence St. Vincent Medical Center offers some of the best care in the ... neurosurgeon and neurointerventionalist, achieved the fastest average blood clot removal time in the country. ...
(Date:8/3/2015)... Pennsylvania (PRWEB) , ... August 03, 2015 , ... Bayer ... Yaz and Yasmin related claims in which a claimant alleged to have suffered an ... related to the birth control pills, Yaz, Yasmin and Ocella, has been ongoing for ...
Breaking Medicine News(10 mins):Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 2Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 3Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 4Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 2Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 3Health News:Article Dispelling Weight Loss Myth Correctly Emphasizes the Complicated and Difficult Nature of Weight Loss, Says Dr. Michael Feiz 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 3Health News:Bayer Agrees To Settle Yaz Aterial Blood Clot Lawsuits 2
... reflect results of new study , , FRIDAY, Jan. 18 (HealthDay ... American women carries a risk of serious blood clots that ... control pill, the U.S. Food and Drug Administration warned ... study that discovered the increased danger, the agency said it ...
... in Vegan Diet War, WASHINGTON, Jan. 18 ... the misleading Physicians Committee,for Responsible Medicine (PCRM) for ... which sued eight restaurant chains this week,over the ... been exposed,in Newsweek and The New York Times ...
... the United States Food and,Drug Administration (FDA) has ... cholesterol lowering medication also indicated for,improving glycemic control ... in,combination with metformin, sulfonylureas, or insulin, when these ... anti-diabetic agents., The ADA estimates that 20.8 ...
... Jan. 18 175 students from,the Academy of Columbus, ... the sixth annual Give Kids A Smile! Day state ... state kick-off will be held in the Atrium at ... from,The Ohio State University College of Dentistry, legislators and ...
... aggressive disease in 2 men taking the product , , ... product described as a dietary supplement appears to have ... two men, researchers report. , "There were things on ... components in the product that were not on the ...
... Part of Available Resources-, JACKSONVILLE, Fla., Jan. ... group of returning wounded veterans are the most ... has expanded,their ever-evolving battery of programs and services ... initiative., The Warriors to Work (WtoW) program ...
Cached Medicine News:Health News:FDA Warns Clot Risk Higher in Birth Control Patch Than Pill 2Health News:FDA Warns Clot Risk Higher in Birth Control Patch Than Pill 3Health News:Phony 'Physicians Committee' Suing Restaurants is Animal-Rights Trojan Horse, says CCF 2Health News:MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS 2Health News:Statehouse Atrium to be Site for Children's Dental Access Event - Ohio Legislators to Mingle With Children and Dentists for This Free Care Event! 2Health News:Mislabled Supplement Spurred Prostate Cancer: Report 2Health News:Mislabled Supplement Spurred Prostate Cancer: Report 3Health News:Wounded Warrior Project (WWP) Expands Service Offerings for Injured Soldiers with the New 'Warriors to Work' Program 2
... HIV-1 Genotyping: The genome of ... in an infected patient, especially in response ... mutations have been shown to render the ... drugs, diminishing the effectiveness of the treatment.,The ...
EIA for Donor Screening. Synthetic peptide Enzyme Immunoassay (EIA) for the detection of antibodies to Human Immunodeficiency Virus Types 1 and/or 2,(HIV-1 and HIV-2) in human serum, plasma or ca...
... The Reveal Rapid HIV-1 Antibody Test (Reveal ... This test detects antibodies in human serum ... by the body in response to HIV ... MedMiras proprietary flow-through membrane technology, and is ...
... The OraQuick ADVANCE ... is a single-use, qualitative ... to Human Immunodeficiency Virus ... Type 2 (HIV-2) in ...
Medicine Products: